Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VeritaScience is a biotechnology company specializing in regenerative medicine and personalized healthcare solutions. As the scientific and laboratory division of the Verita Healthcare Group, the company focuses on the development and clinical application of advanced cell-based therapies, including Natural Killer (NK) cell immunotherapy and Mesenchymal Stem Cell (MSC) treatments. VeritaScience integrates sophisticated diagnostic testing with tailored therapeutic protocols to address complex health challenges such as cancer, chronic inflammation, and age-related decline. The company operates state-of-the-art laboratory facilities that adhere to international quality standards for biological manufacturing. Their mission is to provide evidence-based, personalized medical interventions that enhance longevity and patient outcomes. By leveraging a global network of integrated health centers, VeritaScience delivers cutting-edge treatments directly to patients seeking innovative alternatives to conventional medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VeritaScience.